Sandu Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 19.52 | 16.41 | 17.22 |
| Operating Expense | 18.47 | 15.85 | 16.28 |
| Net Profit | 0.79 | 0.23 | 0.04 |
| Net Profit Margin | 4.05% | 1.40% | 0.23% |
| Earning Per Share | 0.81 | 0.37 | 0.04 |
| EBIDTA | 1.19 | 0.51 | 0.77 |
| Effective Tax Rate | 19.05% | 16.36% | 57.45% |
Particulars
Sep 2026
Revenue19.52
Operating Expense18.47
Net Profit0.79
Net Profit Margin4.05
Earning Per Share0.81
EBIDTA1.19
Effective Tax Rate19.05
